Takara Bio USA Holdings, Inc. acquires Curio Bioscience, expanding its single-cell omics solutions with spatial biology
Acquiring Company
Takara Bio
Acquired Company
Curio Bioscience
Palo AltoPalo AltoBiotechnologyLife ScienceBiotechnologyDescription
Takara Bio USA Holdings, Inc., a leading global biotechnology and life science company, announces the acquisition of Curio Bioscience, a pioneering company in the field of spatial genomics. This strategic acquisition will extend the power of Takara Bio’s NGS solutions, giving customers deeper insights into tissue spatial organization and molecular composition while solidifying its position as a leader in the single-cell genomics market.
Quick answer
Takara Bio is acquiring Curio Bioscience, announced January 15, 2025. Takara Bio is based in Palo Alto, California, United States.
- How much did Takara Bio pay for Curio Bioscience?
- The deal value was not disclosed.
- What does Takara Bio do?
- Takara Bio USA, Inc. is a wholly owned subsidiary of Takara Bio Inc. that manufactures and distributes kits, reagents, and instruments for the life sciences, including NGS, PCR, gene delivery, genome editing, stem cell..
- Where are Takara Bio and Curio Bioscience based?
- Takara Bio is based in Palo Alto, California, United States. Curio Bioscience is based in Palo Alto, California, United States.
- Who are the decision-makers at Takara Bio?
- Fundz holds 3 contacts at Takara Bio. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Life Science and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- VION Biosciences completes acquisition of BioAssay Systems to enhance product offering in life science research (February 5, 2025)
- MediSpend strengthens Governance, Risk and Compliance Solutions through Acquisition of Real Life Sciences (January 27, 2025)
- ActiGraph completes acquisition of Biofourmis Connect to enhance digital health solutions (January 7, 2025)
- Merck Acquires HUB Organoids Holding B.V., Expands Next-Gen Biology Portfolio (January 6, 2025)
- Novo Holdings completes acquisition of Catalent, Inc. (December 18, 2024)
- GSK completes acquisition of IDRx, Inc. to enhance precision therapeutics for treating gastrointestinal stromal tumours (February 24, 2025)
Who to call at Takara Bio, and when
When Takara Bio changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Takara Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Takara Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Takara Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Takara Bio makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Curio Bioscience?
Curio Bioscience was acquired by Takara Bio, based in Palo Alto. The deal was reported on January 15, 2025. Takara Bio USA, Inc. is a wholly owned subsidiary of Takara Bio Inc. Takara Bio is privately held and operates in Biotechnology.
When did Takara Bio acquire Curio Bioscience?
Takara Bio's acquisition of Curio Bioscience was reported on January 15, 2025. Takara Bio USA Holdings, Inc., a leading global biotechnology and life science company, announces the acquisition of Curio Bioscience, a pioneering company in the field of spatial genomics. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Curio Bioscience do?
Curio Bioscience is advancing a new generation of high-precision tools for the life sciences industry. It is privately held, operating in Biotechnology, and is based in Palo Alto.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.